Characterization of the immune response to valve bioprostheses and its role in primary tissue failure

Annals of Thoracic Surgery

Volumn 71, Issue 5 SUPPL., 2001, Pages

  Human, Paul ^a,b   Zilla, Peter ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FREUND ADJUVANT; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA WALL; ATOMIC ABSORPTION SPECTROMETRY; BIOPROSTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT FAILURE; HEART VALVE PROSTHESIS; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SOFT TISSUE CALCIFICATION; SWINE;

EID: 0035011005     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02492-4     Document Type: Conference Paper

References (14)

1. Golomb G, Schoen F, Smith M, et al. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987; 127:122-30.
2. Nimni M, Cheung D, Strates B, et al. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1987;21:741-71.
3. Smith J, Hornick P, Rasmi N, et al. Effect of HLA mismatching, and antibody status on. "homovital" aortic valve homograft performance. Ann Thorac Surg 1998;66:S212-5.
4. Dahm M, Husmann M, Eckhard M, et al. Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves. Ann Thorac Surg 1995;60:S348-52.
5. Eishi K, Ishibashi UH, Nakano K, et al. Calcific degeneration of bioprosthetic aortic valves in patients receiving steroid therapy. J Heart Valve Dis 1996;5:668-72.
6. Chauvaud S, Jebara V, Chachques J, et al. Valve extension with glutaraldehyde-preserved autologous pericardium. Results in mitral valve repair. J Thorac Cardiovasc Surg 1991; 102:171-8.
7. Vincentelli A, Latremouille C, Zegdi R, et al. Does glutaraldehyde induce calcification of bioprosthetic tissues? Ann Thorac Surg 1998;66:S255-8.
8. Zilla P, Fullard L, Trescony P, et al. Glutaraldehyde detoxification of aortic wall tissue: a promising perspective for emerging bioprosthetic valve concepts. J Heart Valve Dis 1997;6:510-20.
9. Dahm M, Lyman W, Schwell A, et al. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg 1990;99:1082-90.
10. Nimni M. The cross-linking and structure modification of the collagen matrix in the design of cardiovascular prosthesis. J Card Surg 1988;3:523-33.
11. Sheikh K, Tascon M, Nimni M. Autoimmunity in patients with Hancock valve implant and bypass heart surgery. Fed Proc 1980;39:472.
12. Zilla P, Weissenstein C, Bracher M, et al. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue. J Heart Valve Dis 1997;6:502-9.
13. Weissenstein C, Human P, Bezuidenhout D, Zilla P. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. J Heart Valve Dis 2000;9:230-40.
14. Zilla P, Weissenstein C, Human P, Dower T, von Oppell UO. High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model. Ann Thorac Surg 2000;70:2091-5.